Skip to content

Clinical trials

Terminated Carcinoma, Non-Small-Cell Lung trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Terminated Country / region: Brazil Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20071
20083
20092
20111
20121
20182
20193
20203
20213
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated23

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Merck Sharp & Dohme LLC3
Pfizer3
Bristol-Myers Squibb2
GlaxoSmithKline2
Hoffmann-La Roche2
Amgen1
Bayer1
BeiGene1
Checkpoint Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung23
Lung Neoplasms4
Neoplasm Metastasis4
Carcinoma3
Carcinoma, Large Cell2
Carcinoma, Squamous Cell2
Neoplasms2
Adenocarcinoma1
Anemia1
Bronchial Diseases1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.